Aethlon Medical Files 8-K
Ticker: AEMD · Form: 8-K · Filed: May 10, 2024 · CIK: 882291
| Field | Detail |
|---|---|
| Company | Aethlon Medical Inc (AEMD) |
| Form Type | 8-K |
| Filed Date | May 10, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
TL;DR
Aethlon Medical filed a routine 8-K, no major news.
AI Summary
Aethlon Medical, Inc. filed an 8-K on May 10, 2024, reporting other events and financial statements. The filing does not contain specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This filing indicates Aethlon Medical, Inc. is meeting its regulatory reporting obligations with the SEC, which is standard for publicly traded companies.
Risk Assessment
Risk Level: low — This is a standard SEC filing for reporting purposes and does not contain new material information that would inherently increase risk.
Key Players & Entities
- Aethlon Medical, Inc. (company) — Registrant
- May 10, 2024 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- 001-37487 (commission_file_number) — SEC File Number
- 13-3632859 (irs_number) — IRS Employer Identification No.
- 11555 Sorrento Valley Road, Suite 203 (address) — Principal executive offices
- San Diego, California (location) — Principal executive offices city and state
- 92121 (zip_code) — Principal executive offices zip code
- 619-941-0360 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for Aethlon Medical, Inc.?
The primary purpose is to report 'Other Events' and 'Financial Statements and Exhibits' as of May 10, 2024.
When was the earliest event reported in this filing?
The earliest event reported was on May 10, 2024.
In which state is Aethlon Medical, Inc. incorporated?
Aethlon Medical, Inc. is incorporated in Nevada.
What is the SEC file number for Aethlon Medical, Inc.?
The SEC file number for Aethlon Medical, Inc. is 001-37487.
What is the principal executive office address for Aethlon Medical, Inc.?
The principal executive office address is 11555 Sorrento Valley Road, Suite 203, San Diego, California 92121.
Filing Stats: 446 words · 2 min read · ~1 pages · Grade level 10.5 · Accepted 2024-05-10 08:01:40
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share AEMD The Nasdaq
Filing Documents
- aethlon_8k.htm (8-K) — 26KB
- aethlon_ex9901.htm (EX-99.1) — 12KB
- image_001.jpg (GRAPHIC) — 15KB
- 0001683168-24-003191.txt ( ) — 233KB
- aemd-20240510.xsd (EX-101.SCH) — 3KB
- aemd-20240510_lab.xml (EX-101.LAB) — 33KB
- aemd-20240510_pre.xml (EX-101.PRE) — 22KB
- aethlon_8k_htm.xml (XML) — 4KB
01
Item 8.01 Other Events. On May 10, 2024, Aethlon Medical, Inc. issued a press release announcing positive results from an in vitro binding study of its Hemopurifier in removing extracellular vesicles from plasma. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Document 99.1 Press Release dated May 10, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: May 10, 2024 Aethlon Medical, Inc. By: /s/ James B. Frakes Name: James B. Frakes Interim Chief Executive Officer and Chief Financial Officer 3